A Prototype Assay Multiplexing SARS-CoV-2 3CL-Protease and Angiotensin-Converting Enzyme 2 for Saliva-Based Diagnostics in COVID-19

With the current state of COVID-19 changing from a pandemic to being more endemic, the priorities of diagnostics will likely vary from rapid detection to stratification for the treatment of the most vulnerable patients. Such patient stratification can be facilitated using multiple markers, including...

Descripción completa

Detalles Bibliográficos
Autores principales: Suresh, Vallabh, Sheik, Daniel A., Detomasi, Tyler C., Zhao, Tianqi, Zepeda, Theresa, Saladi, Shyam, Rajesh, Ummadisetti Chinna, Byers, Kaleb, Craik, Charles S., Davisson, Vincent Jo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377347/
https://www.ncbi.nlm.nih.gov/pubmed/37504081
http://dx.doi.org/10.3390/bios13070682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377347/
https://www.ncbi.nlm.nih.gov/pubmed/37504081
http://dx.doi.org/10.3390/bios13070682

Ejemplares similares